Top Story

CMS releases 2015 Quality Measures Report

March 3, 2015

CMS released the 2015 National Impact Assessment of Quality Measures Report, demonstrating that the nation has made significant progress in improving the health care delivery system to achieve better care, smarter spending and healthier people, the agency announced in a blog post.

“This report is a comprehensive assessment of quality measures used by CMS,” Patrick Conway, MD, deputy administrator for innovation and quality, and chief medical officer at CMS, wrote in the blog. “It examines the effectiveness and impact of measurement and demonstrates our commitment to achieving optimal results from our quality measurement programs.”

Quyen D. Chu, MD, MBA, FACS In the Journals

One-third of patients do not receive recommended post-mastectomy radiation

March 3, 2015
Only 65% of women with breast cancer whose disease spread to four or more nearby lymph nodes underwent recommended radiation therapy after mastectomy, according to study…
In the Journals

Reduced ischemia time may decrease HCC recurrence after liver transplant

March 3, 2015
Reduced cold and warm ischemia times could decrease the risk for hepatocellular carcinoma recurrence after liver transplantation, according to data published in…
FDA NewsDrug Pipeline

FDA grants orphan drug designation to Reolysin for peritoneal cancer

March 3, 2015
The FDA today granted orphan drug designation to pelareorep for the treatment of peritoneal cancer, according to a press release from the drug’s…
Sebastiano Filleti In the Journals

Most benign thyroid nodules remain benign during follow-up

March 3, 2015
A majority of asymptomatic, benign thyroid nodules had no significant change in size after 5 years of follow-up, according to study findings published in JAMA. Thyroid…
More News Headlines »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
thumbnail for video 4040847621001

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »